...
首页> 外文期刊>Progress in nucleic acid research and molecular biology >Major histocompatibility class I folding, assembly, and degradation: a paradigm for two-stage quality control in the endoplasmic reticulum.
【24h】

Major histocompatibility class I folding, assembly, and degradation: a paradigm for two-stage quality control in the endoplasmic reticulum.

机译:主要的组织相容性I类折叠,组装和降解:内质网两阶段质量控制的范例。

获取原文
获取原文并翻译 | 示例
           

摘要

Protein folding in living cells is a complex process involving many interdependent factors. The primary site for folding of nascent proteins destined for secretion is the endoplasmic reticulum (ER). Several disease states, including cystic fibrosis, are brought about because of irregularities in protein folding. Under normal cellular conditions, "quality control" mechanisms ensure that only correctly folded proteins are exported from the ER, with incorrectly folded or incompletely assembled proteins being degraded. Quality control mechanisms can be divided into two broad processes: (1) Primary quality control involves general mechanisms that are not specific for individual proteins; these monitor the fidelity of nascent protein folding in the ER and mediate the destruction of incompletely folded proteins. (2) Partially folded or assembled proteins may be subject to secondary quality control mechanisms that are protein- or protein-family-specific. Here we use the folding and assembly of major histocompatibility complex (MHC) class I as an example to illustrate the processes of quality control in the ER. MHC class I, a trimeric complex assembled in the ER of virally infected or malignant cells, presents antigenic peptide to cytotoxic T lymphocytes; this mediates cell killing and thereby prevents the spread of infection or malignancy. The folding and assembly of MHC class I is subjected to both primary and secondary quality control mechanisms that lead either to correct folding, assembly, and secretion or to degradation via a proteasome-associated mechanism.
机译:活细胞中的蛋白质折叠是一个复杂的过程,涉及许多相互依赖的因素。旨在分泌的新生蛋白质折叠的主要位点是内质网(ER)。由于蛋白质折叠的不规则性,导致了几种疾病状态,包括囊性纤维化。在正常细胞条件下,“质量控制”机制可确保仅将正确折叠的蛋白质从ER中输出,而折叠不正确或组装不完全的蛋白质将被降解。质量控制机制可以分为两个广泛的过程:(1)初级质量控制涉及不针对单个蛋白质的通用机制;这些监测ER中新生蛋白质折叠的保真度,并介导不完全折叠的蛋白质的破坏。 (2)部分折叠或组装的蛋白质可能要接受蛋白质或蛋白质家族特异性的二级质量控制机制。在这里,我们以I类主要组织相容性复合物(MHC)的折叠和组装为例,说明ER中的质量控制过程。 MHC I类是组装在病毒感染或恶性细胞内质网中的三聚体复合物,可向细胞毒性T淋巴细胞呈递抗原性肽。这介导细胞杀伤,从而防止感染或恶性肿瘤扩散。 MHC I类的折叠和组装都受到主要和次要质量控制机制的控制,这些机制会导致正确的折叠,组装和分泌,或者通过蛋白酶体相关机制导致降解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号